生物信息学 实验三、核酸序列分析、常用分子信息学软件使用
更新时间:2023-04-28 12:15:01 阅读量: 实用文档 文档下载
- 生物信息学推荐度:
- 相关推荐
实验三、核酸序列分析、常用分子信息学软件使用
1 、用BioEdit等软件进行序列分析
用BioEdit打开FASTA格式的序列
Sequence-->Nucleic acid-->
1)Sequence-->Nucleic acid-->Nucleotid composition
DNA molecule: gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA
Length = 744 base pairs
Molecular Weight = 227718.00 Daltons, single stranded
Molecular Weight = 453776.00 Daltons, double stranded
G+C content = 61.56%
A+T content = 38.44%
Nucleotide Number Mol%
A 141 18.95
C 251 33.74
G 207 27.82
T 145 19.49
2)Sequence-->Nucleic acid-->Base composition and mass export(monoisotopic)
Title LENGTH A G C T Gap Other Mono_exact_mass BaseComp OppositeStrand_exact_mass OppositeStrand_BaseComp
gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA 744 141 207 251 145 0 0 228830.3528025 A141 G207 C251 T145 230626.6695859 A145 G251 C207 T141
3)Sequence-->Nucleic acid-->Base compoeition and mass export with average masses
Title LENGTH A_COUNT G_COUNT C_COUNT T_COUNT GAP (not used in db) OTHER_COUNT MONO_EXACT_MASS BASE_COMP
OPPOSITE_STRAND_MASS OPPOSITE_STRAND_BASE_COMP SEQUENCE (not used in db) OppositeStrand_Ave_mass
OppositeStrand_BaseComp
gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA 744 141 207 251 145 0 0 228939.3442020 A141 G207 C251 T145 230736.4659940 A145 G251 C207 T141
4)Sequence-->Nucleic acid-->complement CACTGTCGGAGTCTCACCCCAGGAAGACGACTGCTTCTGGTCTCTAGTCTTTACTTTGCTCCGTACTCGTCCCCGA CGTACCGTCACGACCACGACTACCGGTGTCACGACTGACAGTGACCTCGTCAAGGACAGTGGTCCGGGGGGTCCCG GGAGGGCCTACGTTCCCCGACGGTGTATCGGGTCAAGTTCAGAGACAGGGGTGTCCTCGACGTTCGGAAATTCTCT CGGTTTCTACGGAATCTTCTCAGCGAAGACGACTTCCTGACGTCCACGGCGAGGGCGGAGAAGGGGTCCTGGACCC TGGACTCCGTCGACGTCCACTCCCTCGCGGGGCACCGGAACCTCCGACTCGACCGGGACTGCGACCTCCAAGACCT CCGGTGGCGACTGTTACTGTACCGGGACCCACTGCAGGACCTGGCCGGGGAAGTGTGGGACGTGGTGCAGGAGAGG GTCGAGGCCCGGACACAGGTCGGAGTCGGGTGCCGTCCCGGGTCCGGGACCCCAGCGGAGGTGGTGACCGACGTGG CCGAGGTCCTCCGGGGTTTTTTCCTCAGGAGACCGACGGACCTCCGGAGACAGTGGAAGTTGGAGAAGGCGGAGGA GTGCGCCCTGGACTTTACGCAGCGGTCGCCCCTGGACACACGGACTGGAAGGGTGGAGGGACGGTGGGTAGTACGT TAGACTCTAAAATAAATATGTAGTTGGTGAACAGAATTAAATAACGGTGGGTTAGCGATA
5)Sequence-->Nucleic acid-->reverse complement TATCGCTAACCCACCGTTATTTAATTCTGTTCACCAACTACATATTTATTTTAGAGTCTAACGTACTACCCACCGT CCCTCCACCCTTCCAGTCCGTGTGTCCAGGGGCGACCGCTGCGTAAAGTCCAGGGCGCACTCCTCCGCCTTCTCCA ACTTCCACTGTCTCCGGAGGTCCGTCGGTCTCCTGAGGAAAAAACCCCGGAGGACCTCGGCCACGTCGGTCACCAC CTCCGCTGGGGTCCCGGACCCGGGACGGCACCCGACTCCGACCTGTGTCCGGGCCTCGACCCTCTCCTGCACCACG TCCCACACTTCCCCGGCCAGGTCCTGCAGTGGGTCCCGGTACAGTAACAGTCGCCACCGGAGGTCTTGGAGGTCGC AGTCCCGGTCGAGTCGGAGGTTCCGGTGCCCCGCGAGGGAGTGGACGTCGACGGAGTCCAGGGTCCAGGACCCCTT CTCCGCCCTCGCCGTGGACGTCAGGAAGTCGTCTTCGCTGAGAAGATTCCGTAGAAACCGAGAGAATTTCCGAACG TCGAGGACACCCCTGTCTCTGAACTTGACCCGATACACCGTCGGGGAACGTAGGCCCTCCCGGGACCCCCCGGACC
ACTGTCCTTGACGAGGTCACTGTCAGTCGTGACACCGGTAGTCGTGGTCGTGACGGTACGTCGGGGACGAGTACGG AGCAAAGTAAAGACTAGAGACCAGAAGCAGTCGTCTTCCTGGGGTGAGACTCCGACAGTG
6)Sequence-->Nucleic acid-->DNA-->RNA GUGACAGCCUCAGAGUGGGGUCCUUCUGCUGACGAAGACCAGAGAUCAGAAAUGAAACGAGGCAUGAGCAGGGGCU GCAUGGCAGUGCUGGUGCUGAUGGCCACAGUGCUGACUGUCACUGGAGCAGUUCCUGUCACCAGGCCCCCCAGGGC CCUCCCGGAUGCAAGGGGCUGCCACAUAGCCCAGUUCAAGUCUCUGUCCCCACAGGAGCUGCAAGCCUUUAAGAGA GCCAAAGAUGCCUUAGAAGAGUCGCUUCUGCUGAAGGACUGCAGGUGCCGCUCCCGCCUCUUCCCCAGGACCUGGG ACCUGAGGCAGCUGCAGGUGAGGGAGCGCCCCGUGGCCUUGGAGGCUGAGCUGGCCCUGACGCUGGAGGUUCUGGA GGCCACCGCUGACAAUGACAUGGCCCUGGGUGACGUCCUGGACCGGCCCCUUCACACCCUGCACCACGUCCUCUCC CAGCUCCGGGCCUGUGUCCAGCCUCAGCCCACGGCAGGGCCCAGGCCCUGGGGUCGCCUCCACCACUGGCUGCACC GGCUCCAGGAGGCCCCAAAAAAGGAGUCCUCUGGCUGCCUGGAGGCCUCUGUCACCUUCAACCUCUUCCGCCUCCU CACGCGGGACCUGAAAUGCGUCGCCAGCGGGGACCUGUGUGCCUGACCUUCCCACCUCCCUGCCACCCAUCAUGCA AUCUGAGAUUUUAUUUAUACAUCAACCACUUGUCUUAAUUUAUUGCCACCCAAUCGCUAU
7)Sequence-->Nucleic acid-->RNA-->DNA GTGACAGCCTCAGAGTGGGGTCCTTCTGCTGACGAAGACCAGAGATCAGAAATGAAACGAGGCATGAGCAGGGGCT GCATGGCAGTGCTGGTGCTGATGGCCACAGTGCTGACTGTCACTGGAGCAGTTCCTGTCACCAGGCCCCCCAGGGC CCTCCCGGATGCAAGGGGCTGCCACATAGCCCAGTTCAAGTCTCTGTCCCCACAGGAGCTGCAAGCCTTTAAGAGA GCCAAAGATGCCTTAGAAGAGTCGCTTCTGCTGAAGGACTGCAGGTGCCGCTCCCGCCTCTTCCCCAGGACCTGGG ACCTGAGGCAGCTGCAGGTGAGGGAGCGCCCCGTGGCCTTGGAGGCTGAGCTGGCCCTGACGCTGGAGGTTCTGGA GGCCACCGCTGACAATGACATGGCCCTGGGTGACGTCCTGGACCGGCCCCTTCACACCCTGCACCACGTCCTCTCC CAGCTCCGGGCCTGTGTCCAGCCTCAGCCCACGGCAGGGCCCAGGCCCTGGGGTCGCCTCCACCACTGGCTGCACC GGCTCCAGGAGGCCCCAAAAAAGGAGTCCTCTGGCTGCCTGGAGGCCTCTGTCACCTTCAACCTCTTCCGCCTCCT CACGCGGGACCTGAAATGCGTCGCCAGCGGGGACCTGTGTGCCTGACCTTCCCACCTCCCTGCCACCCATCATGCA ATCTGAGATTTTATTTATACATCAACCACTTGTCTTAATTTATTGCCACCCAATCGCTAT
8)Sequence-->Nucleic acid-->Translate
Frame 1:
>gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA
1 GTG ACA GCC TCA GAG TGG GGT CCT TCT GCT GAC GAA GAC CAG AGA 45
1 Val Thr Ala Ser Glu Trp Gly Pro Ser Ala Asp Glu Asp Gln Arg 15
46 TCA GAA ATG AAA CGA GGC ATG AGC AGG GGC TGC ATG GCA GTG CTG 90
16 Ser Glu Met Lys Arg Gly Met Ser Arg Gly Cys Met Ala Val Leu 30
91 GTG CTG ATG GCC ACA GTG CTG ACT GTC ACT GGA GCA GTT CCT GTC 135
31 Val Leu Met Ala Thr Val Leu Thr Val Thr Gly Ala Val Pro Val 45
136 ACC AGG CCC CCC AGG GCC CTC CCG GAT GCA AGG GGC TGC CAC ATA 180
46 Thr Arg Pro Pro Arg Ala Leu Pro Asp Ala Arg Gly Cys His Ile 60
181 GCC CAG TTC AAG TCT CTG TCC CCA CAG GAG CTG CAA GCC TTT AAG 225
61 Ala Gln Phe Lys Ser Leu Ser Pro Gln Glu Leu Gln Ala Phe Lys 75
226 AGA GCC AAA GAT GCC TTA GAA GAG TCG CTT CTG CTG AAG GAC TGC 270
76 Arg Ala Lys Asp Ala Leu Glu Glu Ser Leu Leu Leu Lys Asp Cys 90
271 AGG TGC CGC TCC CGC CTC TTC CCC AGG ACC TGG GAC CTG AGG CAG 315
91 Arg Cys Arg Ser Arg Leu Phe Pro Arg Thr Trp Asp Leu Arg Gln 105
316 CTG CAG GTG AGG GAG CGC CCC GTG GCC TTG GAG GCT GAG CTG GCC 360
106 Leu Gln Val Arg Glu Arg Pro Val Ala Leu Glu Ala Glu Leu Ala 120
361 CTG ACG CTG GAG GTT CTG GAG GCC ACC GCT GAC AAT GAC ATG GCC 405
121 Leu Thr Leu Glu Val Leu Glu Ala Thr Ala Asp Asn Asp Met Ala 135
406 CTG GGT GAC GTC CTG GAC CGG CCC CTT CAC ACC CTG CAC CAC GTC 450
136 Leu Gly Asp Val Leu Asp Arg Pro Leu His Thr Leu His His Val 150
451 CTC TCC CAG CTC CGG GCC TGT GTC CAG CCT CAG CCC ACG GCA GGG 495
151 Leu Ser Gln Leu Arg Ala Cys Val Gln Pro Gln Pro Thr Ala Gly 165
496 CCC AGG CCC TGG GGT CGC CTC CAC CAC TGG CTG CAC CGG CTC CAG 540
166 Pro Arg Pro Trp Gly Arg Leu His His Trp Leu His Arg Leu Gln 180
541 GAG GCC CCA AAA AAG GAG TCC TCT GGC TGC CTG GAG GCC TCT GTC 585
181 Glu Ala Pro Lys Lys Glu Ser Ser Gly Cys Leu Glu Ala Ser Val 195
586 ACC TTC AAC CTC TTC CGC CTC CTC ACG CGG GAC CTG AAA TGC GTC 630
196 Thr Phe Asn Leu Phe Arg Leu Leu Thr Arg Asp Leu Lys Cys Val 210
631 GCC AGC GGG GAC CTG TGT GCC TGA CCT TCC CAC CTC CCT GCC ACC 675
211 Ala Ser Gly Asp Leu Cys Ala End Pro Ser His Leu Pro Ala Thr 225
676 CAT CAT GCA ATC TGA GAT TTT ATT TAT ACA TCA ACC ACT TGT CTT 720
226 His His Ala Ile End Asp Phe Ile Tyr Thr Ser Thr Thr Cys Leu 240
721 AAT TTA TTG CCA CCC AAT CGC TAT 744
241 Asn Leu Leu Pro Pro Asn Arg Tyr
Each codon is read as left nucleotide, top nucleotide, right nucleotide
Each entry is organized as follows:
The number of occurrences of the codon in the sequence
Preference of that codon in organism represented by the codon table
(as a fraction of all codons coding for the same amino acid)
Three-letter code for the amino acid coded for according to the codon table
|A C G T |
----------------------------- A |4 3 2 1 |A
|0.76 0.12 0.04 0.07 | |Lys Thr Arg Ile |
----------------------------- A |1 7 2 1 |C
|0.61 0.43 0.27 0.46 | |Asn Thr Ser Ile |
----------------------------- A |4 3 9 5 |G
|0.24 0.23 0.03 1 |
|Lys Thr Arg Met |
----------------------------- A |3 3 0 1 |T
|0.39 0.21 0.13 0.47 | |Asn Thr Ser Ile |
----------------------------- C |1 3 1 0 |A
|0.31 0.2 0.05 0.03 |
|Gln Pro Arg Leu |
----------------------------- C |8 9 6 10 |C
|0.48 0.1 0.37 0.1 |
|His Pro Arg Leu |
----------------------------- C |9 1 4 20 |G
|0.69 0.55 0.08 0.55 | |Gln Pro Arg Leu |
----------------------------- C |2 5 0 3 |T
|0.52 0.16 0.42 0.1 |
|His Pro Arg Leu |
----------------------------- G |3 5 1 0 |A
|0.7 0.22 0.09 0.17 |
|Glu Ala Gly Val |
----------------------------- G |10 17 4 7 |C
|0.41 0.25 0.4 0.2 |
|Asp Ala Gly Val |
----------------------------- G |11 0 2 6 |G
|0.3 0.34 0.13 0.34 |
|Glu Ala Gly Val |
-----------------------------
G |3 3 3 2 |T
|0.59 0.19 0.38 0.29 |
|Asp Ala Gly Val |
-----------------------------
T |0 3 2 2 |A
|0.62 0.12 0.3 0.11 |
|End Ser End Leu |
-----------------------------
T |0 5 6 4 |C
|0.47 0.17 0.57 0.49 |
|Tyr Ser Cys Phe |
-----------------------------
T |0 1 4 2 |G
|0.09 0.13 1 0.11 |
|End Ser Trp Leu |
-----------------------------
T |2 4 3 2 |T
|0.53 0.19 0.43 0.51 |
|Tyr Ser Cys Phe |
-----------------------------
Frame 2:
>gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA
2 TGA CAG CCT CAG AGT GGG GTC CTT CTG CTG ACG AAG ACC AGA GAT 46
1 End Gln Pro Gln Ser Gly Val Leu Leu Leu Thr Lys Thr Arg Asp 15
47 CAG AAA TGA AAC GAG GCA TGA GCA GGG GCT GCA TGG CAG TGC TGG 91
16 Gln Lys End Asn Glu Ala End Ala Gly Ala Ala Trp Gln Cys Trp 30
92 TGC TGA TGG CCA CAG TGC TGA CTG TCA CTG GAG CAG TTC CTG TCA 136
31 Cys End Trp Pro Gln Cys End Leu Ser Leu Glu Gln Phe Leu Ser 45
137 CCA GGC CCC CCA GGG CCC TCC CGG ATG CAA GGG GCT GCC ACA TAG 181
46 Pro Gly Pro Pro Gly Pro Ser Arg Met Gln Gly Ala Ala Thr End 60
182 CCC AGT TCA AGT CTC TGT CCC CAC AGG AGC TGC AAG CCT TTA AGA 226
61 Pro Ser Ser Ser Leu Cys Pro His Arg Ser Cys Lys Pro Leu Arg 75
227 GAG CCA AAG ATG CCT TAG AAG AGT CGC TTC TGC TGA AGG ACT GCA 271 76 Glu Pro Lys Met Pro End Lys Ser Arg Phe Cys End Arg Thr Ala 90
272 GGT GCC GCT CCC GCC TCT TCC CCA GGA CCT GGG ACC TGA GGC AGC 316 91 Gly Ala Ala Pro Ala Ser Ser Pro Gly Pro Gly Thr End Gly Ser 105
317 TGC AGG TGA GGG AGC GCC CCG TGG CCT TGG AGG CTG AGC TGG CCC 361 106 Cys Arg End Gly Ser Ala Pro Trp Pro Trp Arg Leu Ser Trp Pro 120
362 TGA CGC TGG AGG TTC TGG AGG CCA CCG CTG ACA ATG ACA TGG CCC 406 121 End Arg Trp Arg Phe Trp Arg Pro Pro Leu Thr Met Thr Trp Pro 135
407 TGG GTG ACG TCC TGG ACC GGC CCC TTC ACA CCC TGC ACC ACG TCC 451 136 Trp Val Thr Ser Trp Thr Gly Pro Phe Thr Pro Cys Thr Thr Ser 150
452 TCT CCC AGC TCC GGG CCT GTG TCC AGC CTC AGC CCA CGG CAG GGC 496 151 Ser Pro Ser Ser Gly Pro Val Ser Ser Leu Ser Pro Arg Gln Gly 165
497 CCA GGC CCT GGG GTC GCC TCC ACC ACT GGC TGC ACC GGC TCC AGG 541 166 Pro Gly Pro Gly Val Ala Ser Thr Thr Gly Cys Thr Gly Ser Arg 180
542 AGG CCC CAA AAA AGG AGT CCT CTG GCT GCC TGG AGG CCT CTG TCA 586 181 Arg Pro Gln Lys Arg Ser Pro Leu Ala Ala Trp Arg Pro Leu Ser 195
587 CCT TCA ACC TCT TCC GCC TCC TCA CGC GGG ACC TGA AAT GCG TCG 631 196 Pro Ser Thr Ser Ser Ala Ser Ser Arg Gly Thr End Asn Ala Ser 210
632 CCA GCG GGG ACC TGT GTG CCT GAC CTT CCC ACC TCC CTG CCA CCC 676 211 Pro Ala Gly Thr Cys Val Pro Asp Leu Pro Thr Ser Leu Pro Pro 225
677 ATC ATG CAA TCT GAG ATT TTA TTT ATA CAT CAA CCA CTT GTC TTA 721 226 Ile Met Gln Ser Glu Ile Leu Phe Ile His Gln Pro Leu Val Leu 240
722 ATT TAT TGC CAC CCA ATC GCT 742
241 Ile Tyr Cys His Pro Ile Ala 247
Each codon is read as left nucleotide, top nucleotide, right nucleotide Each entry is organized as follows:
The number of occurrences of the codon in the sequence
Preference of that codon in organism represented by the codon table (as a fraction of all codons coding for the same amino acid)
Three-letter code for the amino acid coded for according to the codon table
|A C G T |
-----------------------------
A |2 4 2 1 |A
|0.76 0.12 0.04 0.07 |
|Lys Thr Arg Ile |
-----------------------------
A |1 10 7 2 |C
|0.61 0.43 0.27 0.46 |
|Asn Thr Ser Ile |
-----------------------------
A |4 3 10 4 |G
|0.24 0.23 0.03 1 |
|Lys Thr Arg Met |
-----------------------------
A |1 2 5 2 |T
|0.39 0.21 0.13 0.47 |
|Asn Thr Ser Ile |
-----------------------------
C |4 12 0 0 |A
|0.31 0.2 0.05 0.03 |
|Gln Pro Arg Leu |
-----------------------------
C |2 13 3 2 |C
|0.48 0.1 0.37 0.1 |
|His Pro Arg Leu |
-----------------------------
C |7 2 2 10 |G
|0.69 0.55 0.08 0.55 |
|Gln Pro Arg Leu |
-----------------------------
C |1 11 0 3 |T
|0.52 0.16 0.42 0.1 |
|His Pro Arg Leu |
-----------------------------
G |0 4 1 0 |A
|0.7 0.22 0.09 0.17 |
|Glu Ala Gly Val |
-----------------------------
G |1 7 7 3 |C
|0.41 0.25 0.4 0.2 |
|Asp Ala Gly Val |
-----------------------------
G |4 2 10 3 |G
|0.3 0.34 0.13 0.34 |
|Glu Ala Gly Val |
-----------------------------
G |1 5 1 0 |T
|0.59 0.19 0.38 0.29 |
|Asp Ala Gly Val |
-----------------------------
T |0 6 10 3 |A
|0.62 0.12 0.3 0.11 |
|End Ser End Leu |
-----------------------------
T |0 11 9 4 |C
|0.47 0.17 0.57 0.49 |
|Tyr Ser Cys Phe |
-----------------------------
T |2 1 12 0 |G
|0.09 0.13 1 0.11 |
|End Ser Trp Leu |
-----------------------------
T |1 4 2 1 |T
|0.53 0.19 0.43 0.51 |
|Tyr Ser Cys Phe |
-----------------------------
Frame3:
>gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA
3 GAC AGC CTC AGA GTG GGG TCC TTC TGC TGA CGA AGA CCA GAG ATC 47
0 Asp Ser Leu Arg Val Gly Ser Phe Cys End Arg Arg Pro Glu Ile 14
48 AGA AAT GAA ACG AGG CAT GAG CAG GGG CTG CAT GGC AGT GCT GGT 92
15 Arg Asn Glu Thr Arg His Glu Gln Gly Leu His Gly Ser Ala Gly 29
93 GCT GAT GGC CAC AGT GCT GAC TGT CAC TGG AGC AGT TCC TGT CAC 137
30 Ala Asp Gly His Ser Ala Asp Cys His Trp Ser Ser Ser Cys His 44
138 CAG GCC CCC CAG GGC CCT CCC GGA TGC AAG GGG CTG CCA CAT AGC 182
45 Gln Ala Pro Gln Gly Pro Pro Gly Cys Lys Gly Leu Pro His Ser 59
183 CCA GTT CAA GTC TCT GTC CCC ACA GGA GCT GCA AGC CTT TAA GAG 227
60 Pro Val Gln Val Ser Val Pro Thr Gly Ala Ala Ser Leu End Glu 74
228 AGC CAA AGA TGC CTT AGA AGA GTC GCT TCT GCT GAA GGA CTG CAG 272 75 Ser Gln Arg Cys Leu Arg Arg Val Ala Ser Ala Glu Gly Leu Gln 89
273 GTG CCG CTC CCG CCT CTT CCC CAG GAC CTG GGA CCT GAG GCA GCT 317 90 Val Pro Leu Pro Pro Leu Pro Gln Asp Leu Gly Pro Glu Ala Ala 104
318 GCA GGT GAG GGA GCG CCC CGT GGC CTT GGA GGC TGA GCT GGC CCT 362 105 Ala Gly Glu Gly Ala Pro Arg Gly Leu Gly Gly End Ala Gly Pro 119
363 GAC GCT GGA GGT TCT GGA GGC CAC CGC TGA CAA TGA CAT GGC CCT 407 120 Asp Ala Gly Gly Ser Gly Gly His Arg End Gln End His Gly Pro 134
408 GGG TGA CGT CCT GGA CCG GCC CCT TCA CAC CCT GCA CCA CGT CCT 452 135 Gly End Arg Pro Gly Pro Ala Pro Ser His Pro Ala Pro Arg Pro 149
453 CTC CCA GCT CCG GGC CTG TGT CCA GCC TCA GCC CAC GGC AGG GCC 497 150 Leu Pro Ala Pro Gly Leu Cys Pro Ala Ser Ala His Gly Arg Ala 164
498 CAG GCC CTG GGG TCG CCT CCA CCA CTG GCT GCA CCG GCT CCA GGA 542 165 Gln Ala Leu Gly Ser Pro Pro Pro Leu Ala Ala Pro Ala Pro Gly 179
543 GGC CCC AAA AAA GGA GTC CTC TGG CTG CCT GGA GGC CTC TGT CAC 587 180 Gly Pro Lys Lys Gly Val Leu Trp Leu Pro Gly Gly Leu Cys His 194
588 CTT CAA CCT CTT CCG CCT CCT CAC GCG GGA CCT GAA ATG CGT CGC 632 195 Leu Gln Pro Leu Pro Pro Pro His Ala Gly Pro Glu Met Arg Arg 209
633 CAG CGG GGA CCT GTG TGC CTG ACC TTC CCA CCT CCC TGC CAC CCA 677 210 Gln Arg Gly Pro Val Cys Leu Thr Phe Pro Pro Pro Cys His Pro 224
678 TCA TGC AAT CTG AGA TTT TAT TTA TAC ATC AAC CAC TTG TCT TAA 722 225 Ser Cys Asn Leu Arg Phe Tyr Leu Tyr Ile Asn His Leu Ser End 239
723 TTT ATT GCC ACC CAA TCG CTA 743
240 Phe Ile Ala Thr Gln Ser Leu 246
Each codon is read as left nucleotide, top nucleotide, right nucleotide Each entry is organized as follows:
The number of occurrences of the codon in the sequence
Preference of that codon in organism represented by the codon table
(as a fraction of all codons coding for the same amino acid)
Three-letter code for the amino acid coded for according to the codon table
|A C G T |
-----------------------------
A |2 1 7 0 |A
|0.76 0.12 0.04 0.07 |
|Lys Thr Arg Ile |
-----------------------------
A |1 2 5 2 |C
|0.61 0.43 0.27 0.46 |
|Asn Thr Ser Ile |
-----------------------------
A |1 1 2 1 |G
|0.24 0.23 0.03 1 |
|Lys Thr Arg Met |
-----------------------------
A |2 0 3 1 |T
|0.39 0.21 0.13 0.47 |
|Asn Thr Ser Ile |
-----------------------------
C |5 11 1 1 |A
|0.31 0.2 0.05 0.03 |
|Gln Pro Arg Leu |
-----------------------------
C |10 7 2 5 |C
|0.48 0.1 0.37 0.1 |
|His Pro Arg Leu |
-----------------------------
C |7 6 1 10 |G
|0.69 0.55 0.08 0.55 |
|Gln Pro Arg Leu |
-----------------------------
C |4 17 4 6 |T
|0.52 0.16 0.42 0.1 |
|His Pro Arg Leu |
-----------------------------
G |3 5 14 0 |A
|0.7 0.22 0.09 0.17 |
|Glu Ala Gly Val |
-----------------------------
G |4 7 12 4 |C
|0.41 0.25 0.4 0.2 |
|Asp Ala Gly Val |
-----------------------------
G |5 2 5 3 |G
|0.3 0.34 0.13 0.34 |
|Glu Ala Gly Val |
-----------------------------
G |1 12 3 1 |T
|0.59 0.19 0.38 0.29 |
|Asp Ala Gly Val |
-----------------------------
T |2 3 5 1 |A
|0.62 0.12 0.3 0.11 |
|End Ser End Leu |
-----------------------------
T |1 2 6 2 |C
|0.47 0.17 0.57 0.49 |
|Tyr Ser Cys Phe |
-----------------------------
T |0 2 2 1 |G
|0.09 0.13 1 0.11 |
|End Ser Trp Leu |
-----------------------------
T |1 4 4 2 |T
|0.53 0.19 0.43 0.51 |
|Tyr Ser Cys Phe |
-----------------------------
Section:
>gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA
1 GTG ACA GCC TCA GAG TGG GGT CCT TCT GCT GAC GAA GAC CAG AGA 45
1 Val Thr Ala Ser Glu Trp Gly Pro Ser Ala Asp Glu Asp Gln Arg 15
46 TCA GAA ATG AAA CGA GGC ATG AGC AGG GGC TGC ATG GCA GTG CTG 90
16 Ser Glu Met Lys Arg Gly Met Ser Arg Gly Cys Met Ala Val Leu 30
91 GTG CTG ATG GCC ACA GTG CTG ACT GTC ACT GGA GCA GTT CCT GTC 135
31 Val Leu Met Ala Thr Val Leu Thr Val Thr Gly Ala Val Pro Val 45
136 ACC AGG CCC CCC AGG GCC CTC CCG GAT GCA AGG GGC TGC CAC ATA 180
46 Thr Arg Pro Pro Arg Ala Leu Pro Asp Ala Arg Gly Cys His Ile 60
181 GCC CAG TTC AAG TCT CTG TCC CCA CAG GAG CTG CAA GCC TTT AAG 225 61 Ala Gln Phe Lys Ser Leu Ser Pro Gln Glu Leu Gln Ala Phe Lys 75
226 AGA GCC AAA GAT GCC TTA GAA GAG TCG CTT CTG CTG AAG GAC TGC 270 76 Arg Ala Lys Asp Ala Leu Glu Glu Ser Leu Leu Leu Lys Asp Cys 90
271 AGG TGC CGC TCC CGC CTC TTC CCC AGG ACC TGG GAC CTG AGG CAG 315 91 Arg Cys Arg Ser Arg Leu Phe Pro Arg Thr Trp Asp Leu Arg Gln 105
316 CTG CAG GTG AGG GAG CGC CCC GTG GCC TTG GAG GCT GAG CTG GCC 360 106 Leu Gln Val Arg Glu Arg Pro Val Ala Leu Glu Ala Glu Leu Ala 120
361 CTG ACG CTG GAG GTT CTG GAG GCC ACC GCT GAC AAT GAC ATG GCC 405 121 Leu Thr Leu Glu Val Leu Glu Ala Thr Ala Asp Asn Asp Met Ala 135
406 CTG GGT GAC GTC CTG GAC CGG CCC CTT CAC ACC CTG CAC CAC GTC 450 136 Leu Gly Asp Val Leu Asp Arg Pro Leu His Thr Leu His His Val 150
451 CTC TCC CAG CTC CGG GCC TGT GTC CAG CCT CAG CCC ACG GCA GGG 495 151 Leu Ser Gln Leu Arg Ala Cys Val Gln Pro Gln Pro Thr Ala Gly 165
496 CCC AGG CCC TGG GGT CGC CTC CAC CAC TGG CTG CAC CGG CTC CAG 540 166 Pro Arg Pro Trp Gly Arg Leu His His Trp Leu His Arg Leu Gln 180
541 GAG GCC CCA AAA AAG GAG TCC TCT GGC TGC CTG GAG GCC TCT GTC 585 181 Glu Ala Pro Lys Lys Glu Ser Ser Gly Cys Leu Glu Ala Ser Val 195
586 ACC TTC AAC CTC TTC CGC CTC CTC ACG CGG GAC CTG AAA TGC GTC 630 196 Thr Phe Asn Leu Phe Arg Leu Leu Thr Arg Asp Leu Lys Cys Val 210
631 GCC AGC GGG GAC CTG TGT GCC TGA CCT TCC CAC CTC CCT GCC ACC 675 211 Ala Ser Gly Asp Leu Cys Ala End Pro Ser His Leu Pro Ala Thr 225
676 CAT CAT GCA ATC TGA GAT TTT ATT TAT ACA TCA ACC ACT TGT CTT 720 226 His His Ala Ile End Asp Phe Ile Tyr Thr Ser Thr Thr Cys Leu 240
721 AAT TTA TTG CCA CCC AAT CGC TAT 744
241 Asn Leu Leu Pro Pro Asn Arg Tyr
Each codon is read as left nucleotide, top nucleotide, right nucleotide Each entry is organized as follows:
The number of occurrences of the codon in the sequence
Preference of that codon in organism represented by the codon table
(as a fraction of all codons coding for the same amino acid)
Three-letter code for the amino acid coded for according to the codon table
|A C G T |
-----------------------------
A |4 3 2 1 |A
|0.76 0.12 0.04 0.07 |
|Lys Thr Arg Ile |
-----------------------------
A |1 7 2 1 |C
|0.61 0.43 0.27 0.46 |
|Asn Thr Ser Ile |
-----------------------------
A |4 3 9 5 |G
|0.24 0.23 0.03 1 |
|Lys Thr Arg Met |
-----------------------------
A |3 3 0 1 |T
|0.39 0.21 0.13 0.47 |
|Asn Thr Ser Ile |
-----------------------------
C |1 3 1 0 |A
|0.31 0.2 0.05 0.03 |
|Gln Pro Arg Leu |
-----------------------------
C |8 9 6 10 |C
|0.48 0.1 0.37 0.1 |
|His Pro Arg Leu |
-----------------------------
C |9 1 4 20 |G
|0.69 0.55 0.08 0.55 |
|Gln Pro Arg Leu |
-----------------------------
C |2 5 0 3 |T
|0.52 0.16 0.42 0.1 |
|His Pro Arg Leu |
-----------------------------
G |3 5 1 0 |A
|0.7 0.22 0.09 0.17 |
|Glu Ala Gly Val |
-----------------------------
G |10 17 4 7 |C
|0.41 0.25 0.4 0.2 |
|Asp Ala Gly Val |
-----------------------------
G |11 0 2 6 |G
|0.3 0.34 0.13 0.34 |
|Glu Ala Gly Val |
-----------------------------
G |3 3 3 2 |T
|0.59 0.19 0.38 0.29 |
|Asp Ala Gly Val |
-----------------------------
T |0 3 2 2 |A
|0.62 0.12 0.3 0.11 |
|End Ser End Leu |
-----------------------------
T |0 5 6 4 |C
|0.47 0.17 0.57 0.49 |
|Tyr Ser Cys Phe |
-----------------------------
T |0 1 4 2 |G
|0.09 0.13 1 0.11 |
|End Ser Trp Leu |
-----------------------------
T |2 4 3 2 |T
|0.53 0.19 0.43 0.51 |
|Tyr Ser Cys Phe |
-----------------------------
9)Sequence-->Nucleic acid-->Find next ORF ATGAAACGAGGCATGAGCAGGGGCTGCATGGCAGTGCTGGTGCTGATGGCCACAGTGCTGACTGTCACTGGAGCAG TTCCTGTCACCAGGCCCCCCAGGGCCCTCCCGGATGCAAGGGGCTGCCACATAGCCCAGTTCAAGTCTCTGTCCCC ACAGGAGCTGCAAGCCTTTAAGAGAGCCAAAGATGCCTTAGAAGAGTCGCTTCTGCTGAAGGACTGCAGGTGCCGC TCCCGCCTCTTCCCCAGGACCTGGGACCTGAGGCAGCTGCAGGTGAGGGAGCGCCCCGTGGCCTTGGAGGCTGAGC TGGCCCTGACGCTGGAGGTTCTGGAGGCCACCGCTGACAATGACATGGCCCTGGGTGACGTCCTGGACCGGCCCCT TCACACCCTGCACCACGTCCTCTCCCAGCTCCGGGCCTGTGTCCAGCCTCAGCCCACGGCAGGGCCCAGGCCCTGG GGTCGCCTCCACCACTGGCTGCACCGGCTCCAGGAGGCCCCAAAAAAGGAGTCCTCTGGCTGCCTGGAGGCCTCTG TCACCTTCAACCTCTTCCGCCTCCTCACGCGGGACCTGAAATGCGTCGCCAGCGGGGACCTGTGTGCCTGA
10)Sequence-->Nucleic acid-->Creat Plasmid from Sequence
11)Restriction map
BioEdit version 7.0.9.0 (6/27/07) Restriction Mapping Utility
(c)1998, Tom Hall
gi|725605238|ref|XM_010330964.1| PREDICTED: Saimiri boliviensis boliviensis interferon, lambda 3 (IFNL3), mRNA Restriction Map
2014/11/29 17:27:57
744 base pairs
Translations: 3 2 1 -1 -2 -3
Restriction Enzyme Map:
D S L R V G S F C * R R P
E I R N E T R H E Q G L H
* Q P Q S G V L L L T K T R D Q K * N E A * A G A A
V T A S E W G P S A D E D Q R S E M K R G M S R G C M
1 GTGACAGCCTCAGAGTGGGGTCCTTCTGCTGACGAAGACCAGAGA TCAGAAATGAAACGAGGCA TGAGCAGGGGCTGCAT 80
1 CACTGTCGGAGTCTCACCCCAGGAAGACGACTGCTTCTGGTCTCTAGTCTTTACTTTGCTCCGTACTCGTCCCCGACGTA 80
H C G * L P T R R S V F V L S * F H F S A H A P A A H
V A E S H P G E A S S S W L D S I F R P M L L P Q M
S L R L T P D K Q Q R L G S I L F S V L C S C P S C
BslI NlaIV Hin4I BbsI MnlI Hin4I TspDTI HpyF10VI
MnlI Hin4I MboII Hin4I BstAPI
EcoO109I BbvI MwoI
PpuMI AlwNI
BspCNI
BseMII
G S A G A D G H S A D C H W S S S C H Q A P Q G P P G
W Q C W C * W P Q C * L S L E Q F L S P G P P G P S R
A V L V L M A T V L T V T G A V P V T R P P R A L P
81 GGCAGTGCTGGTGCTGA TGGCCACAGTGCTGACTGTCACTGGAGCAGTTCCTGTCACCAGGCCCCCCAGGGCCCTCCCGG 160
81 CCGTCACGACCACGACTACCGGTGTCACGACTGACAGTGACCTCGTCAAGGACAGTGGTCCGGGGGGTCCCGGGAGGGCC 160
C H Q H Q H G C H Q S
D S S C N R D G P G G P G
E R
A T S T S I A V T S V T V P A T G T V L G G L A R G S
P L A P A S P W L A S Q * Q L L E Q * W A G W P G G P
MslI TspRI EaeI TspRI TspRI AlwNI BpmI BsaJI ApaI
BtsI MscI BsrI Eco57MI EcoO109I
HphI EcoO109I EcoO109I
NlaIV PspOMI BbvI
BsaJI BanII
SfaNI
NlaIV
Bme1580I
Bsp1286I
C K G L P H S P V Q V S V P T G A A S L * E S Q R C
M Q G A A T * P S S S L C P H R S C K P L R E P K M P
D A R G C H I A Q F K S L S P Q
E L Q A
F K R A K D A
161 A TGCAAGGGGCTGCCACA TAGCCCAGTTCAAGTCTCTGTCCCCACAGGAGCTGCAAGCCTTTAAGAGAGCCAAAGA TGCC 240 161 TACGTTCCCCGACGGTGTA TCGGGTCAAGTTCAGAGACAGGGGTGTCCTCGACGTTCGGAAATTCTCTCGGTTTCTACGG 240
I C P A A V Y G L E L R Q G W L L Q L G K L S G F I G
A L P Q W M A W N L D R D G C S S C A K L L A L S A
H L P S G C L G T * T E T G V P A A L R * S L W L H R
MnlI FokI BsrI BsmAI AlwNI SfaNI MwoI
BstF5I BmrI BsmFI BbvI Cac8I HpyF10VI
FalI
EarI
L R R V A S A E G L Q V P L P P L P Q D L G P E A A A
* K S R F C * R T A G A A P A S S P G P G T * G S C
L E E S L L L K D C R C R S R L F P R T W D L R Q L Q
241 TTAGAAGAGTCGCTTCTGCTGAAGGACTGCAGGTGCCGCTCCCGCCTCTTCCCCAGGACCTGGGACCTGAGGCAGCTGCA 320 241 AA TCTTCTCAGCGAAGACGACTTCCTGACGTCCACGGCGAGGGCGGAGAAGGGGTCCTGGACCCTGGACTCCGTCGACGT 320 * F L R K Q Q L V A P A A G A E E G P G P V Q P L Q L
K S S D S R S F S Q L H R E R R K G L V Q S R L C S C
L L T A E A S P S C T G S G G R G W S R P G S A A A
PleI SfcI NlaIV MwoI FauI MnlI MnlI AarI MspA1I
MboII FalI MwoI HpyF10VI EarI BseMII Bsu36I PvuII
MlyI PstI BsrBI BsaJI BslI BspMI BsmFI
AarI BanI MboII EcoO109I SfcI
BspMI HpyF10VI PpuMI EcoO109I MnlI
Eco57I PflMI
Eco57MI AlwNI
BspCNI
BsaJI
BbvI
PpuMI
NlaIV
G E G A P R G L G G * A G P D A G G S G G H R * Q * H
R * G S A P W P W R L S W P * R W R F W R P P L T M T
V R E R P V A L E A E L A L T L E V L E A T A D N D
321 GGTGAGGGAGCGCCCCGTGGCCTTGGAGGCTGAGCTGGCCCTGACGCTGGAGGTTCTGGAGGCCACCGCTGACAATGACA 400 321 CCACTCCCTCGCGGGGCACCGGAACCTCCGACTCGACCGGGACTGCGACCTCCAAGACCTCCGGTGGCGACTGTTACTGT 400
H P L A G H G Q L S L Q G Q R Q L N Q L G G S V I V
T L S R G T A K S A S S A R V S S T R S A V A S L S M
P S P A G R P R P P Q A P G S A P P E P P W R Q C H C
PstI HphI MnlI BglI MwoI MnlI HgaI BpmI BpmI
BbvI HaeII BseMII BlpI HpyF10VI BslI MnlI Eco57MI Eco57MI
BsaJI BspCNI Cac8I Hpy188III MspA1I TaqII
BtgI BsaJI
StyI HpyF10VI
MwoI
G P G * R P G P A P S H P A P R P L P A P G L C P A
W P W V T S W T G P F T P C T T S S P S S G P V S S L
M A L G D V L D R P L H T L H H V L S Q L R A C V Q P
401 TGGCCCTGGGTGACGTCCTGGACCGGCCCCTTCACACCCTGCACCACGTCCTCTCCCAGCTCCGGGCCTGTGTCCAGCCT 480 401 ACCGGGACCCACTGCAGGACCTGGCCGGGGAAGTGTGGGACGTGGTGCAGGAGAGGGTCGAGGCCCGGACACAGGTCGGA 480
H G Q T V D Q V P G K V G Q V V D E G L E P G T D L R
A R P S T R S R G R * V R C W T R E W S R A Q T W G
P G P H R G P G A G E C G A G R G R G A G P R H G A E
BsaJI BsaHI HphI NlaIV BsaXI BmgBI BseYI BslI BbvCI
BsaJI ZraI BsrFI MnlI BsaXI Bpu10I
AatII BsgI BslI
S A H G R A Q A L G S P P P L A A P A P G G P K K G V
S P R Q G P G P G V A S T T G C T G S R R P Q K R S
Q P T A G P R P W G R L H H W L H R L Q E A P K K E S
481 CAGCCCACGGCAGGGCCCAGGCCCTGGGGTCGCCTCCACCACTGGCTGCACCGGCTCCAGGAGGCCCCAAAAAAGGAGTC 560 481 GTCGGGTGCCGTCCCGGGTCCGGGACCCCAGCGGAGGTGGTGACCGACGTGGCCGAGGTCCTCCGGGGTTTTTTCCTCAG 560 L G R C P G P G P T A E V V P Q V P E L L G W F L L G
* G V A P G L G Q P R R W W Q S C R S W S A G F F S D
A W P L A W A R P D G G G S A A G A G P P G L F P T
BsaJI BspCNI EcoO109I BsgI BpmI TspRI MnlI EcoO109I BbvI
BtgI BslI ApaI BceAI BbvI Eco57MI BsrFI BslI NlaIV BslI
MnlI NlaIV BsaJI MnlI MwoI
BslI BsaJI BslI BsrI HpyF10VI
BseMII PflMI NlaIV
EcoO109I AlwNI
PspOMI BsaJI
BanII
Bme1580I
Bsp1286I
L W L P G G L C H L Q P L P P P H A G P E M R R Q R G
P L A A W R P L S P S T S S A S S R G T * N A S P A G
S G C L E A S V T F N L F R L L T R D L K C V A S G
561 CTCTGGCTGCCTGGAGGCCTCTGTCACCTTCAACCTCTTCCGCCTCCTCACGCGGGACCTGAAATGCGTCGCCAGCGGGG 640 561 GAGACCGACGGACCTCCGGAGACAGTGGAAGTTGGAGAAGGCGGAGGAGTGCGCCCTGGACTTTACGCAGCGGTCGCCCC 640 R A A Q L G R D G E V E E A E E R P V Q F A D G A P
E P Q R S A E T V K L R K R R R V R S R
F H T A L P S
R Q S G P P R Q * R * G R G G G * A P G S I R R W R P
PleI MnlI HphI MnlI BseRI MnlI BslI BsmFI MspA1I
MlyI StuI MboII EarI MnlI FauI EcoO109I
MnlI EciI FauI EcoO109I MwoI PpuMI
BpmI PpuMI HpyF10VI
Eco57MI HgaI Cac8I
MnlI
NlaIV
P V C L T F P P P C H P S C N L R F Y L Y I N H L S
T C V P D L P T S L P P I M Q S E I L F I H Q P L V L
D L C A * P S H L P A T H H A I * D F I Y T S T T C L
641 ACCTGTGTGCCTGACCTTCCCACCTCCCTGCCACCCA TCA TGCAA TCTGAGA TTTTA TTTA TACATCAACCACTTGTCTT 720
641 TGGACACACGGACTGGAAGGGTGGAGGGACGGTGGGTAGTACGTTAGACTCTAAAA TAAA TATGTAGTTGGTGAACAGAA 720 V Q T G S R G V E R G G M M C D S I K N I C * G S T K
R H A Q G E W R G A V W * A I Q S K I * V D V V Q R
G T H R V K G G G Q W G D H L R L N * K Y M L W K D *
NlaIV BsmFI MnlI BspCNI TaqII
BseMII
* F I A T Q S L
I Y C H P I A
N L L P P N R Y
721 AA TTTA TTGCCACCCAA TCGCTAT 744
721 TTAAA TAACGGTGGGTTAGCGATA 744
I * Q W G I A I
L K N G G L R *
N I A V W D S
Restriction table:
Enzyme Recognition frequency Positions
__________________________________________________________________________ AarI CACCTGCnnnn'nnnn_ 2 261, 310
AatII G_ACGT'C 1 417
AlwNI CAG_nnn'CTG 5 75, 131, 211, 300, 504
ApaI G_GGCC'C 2 154, 498
BanI G'GyrC_C 1 273
BanII G_rGCy'C 2 154, 498
BbsI GAAGACnn'nnnn_ 1 42
BbvI GCAGCnnnnnnnn'nnnn_ 7 62, 158, 198, 303, 325, 513, 554 BbvCI CC'TCA_GC 1 480
BceAI ACGGCnnnnnnnnnnnn'nn_ 1 504
BglI GCCn_nnn'nGGC 1 347
BlpI GC'TnA_GC 1 351
Bme1580I G_kGCm'C 2 154, 498
BmgBI CAC'GTC 1 448
BmrI ACTGGGnnnn_n' 1 178
BpmI CTGGAGnnnnnnnnnnnnnn_nn' 5 141, 389, 398, 521, 593
Bpu10I CC'TnA_GC 1 480
BsaHI Gr'CG_yC 1 414
BsaJI C'CnnG_G 12 146, 147, 293, 300, 336, 342
405, 406, 486, 497, 503, 504 BsaXI ACnnnnnCTCCnnnnnnn_nnn' 1 467
BsaXI GGAGnnnnnGTnnnnnnnnn_nnn' 1 437
BseMII CTCAGnnnnnnnn_nn' 5 24, 299, 342, 494, 679
正在阅读:
生物信息学 实验三、核酸序列分析、常用分子信息学软件使用04-28
我与篆刻作文800字07-15
怎样能使电脑上网及操作速度快一些05-28
铜陵会计培训从业资格考试会计电算化专项练习多选(9月13日)04-01
六年级下册英语期末测试卷(江苏南通真卷)译林版(三起)【最新】04-14
2012年徐海学院考研情况统计xls - 中国矿业大学徐海学院07-26
高致病性禽流感防治知识问答04-11
庆阳市领军人才队伍建设实施意见07-19
- 教学能力大赛决赛获奖-教学实施报告-(完整图文版)
- 互联网+数据中心行业分析报告
- 2017上海杨浦区高三一模数学试题及答案
- 招商部差旅接待管理制度(4-25)
- 学生游玩安全注意事项
- 学生信息管理系统(文档模板供参考)
- 叉车门架有限元分析及系统设计
- 2014帮助残疾人志愿者服务情况记录
- 叶绿体中色素的提取和分离实验
- 中国食物成分表2020年最新权威完整改进版
- 推动国土资源领域生态文明建设
- 给水管道冲洗和消毒记录
- 计算机软件专业自我评价
- 高中数学必修1-5知识点归纳
- 2018-2022年中国第五代移动通信技术(5G)产业深度分析及发展前景研究报告发展趋势(目录)
- 生产车间巡查制度
- 2018版中国光热发电行业深度研究报告目录
- (通用)2019年中考数学总复习 第一章 第四节 数的开方与二次根式课件
- 2017_2018学年高中语文第二单元第4课说数课件粤教版
- 上市新药Lumateperone(卢美哌隆)合成检索总结报告
- 核酸
- 信息
- 软件使用
- 序列
- 分子
- 常用
- 实验
- 生物
- 分析
- 初三主题班会策划书
- 大学生两分钟演讲稿【五篇】
- 三年级数学上册口算题大全108
- ERP系统管理制度(物资管理模块)
- 苏科版八年级物理下实验题专项训练
- 低渗透油藏储层精细描述与剩余油分布规律——以D31井区长1油藏为例
- 2015-2016学年福建省福州格致中学高二上学期半期考试化学试卷(带解析)
- 新材料业2018年投资策略较全
- 01-小升初专项复习——语文_小学生必背的80首古诗词的填空题
- 在线精品课程建设方案详细
- 重庆科技学院大学计算机基础考试题
- 初级专业技术职务任职资格申报表
- 工业循环水处理技术项目可行性报告(2013年发改委评审通过案例范文)-专家免费咨询
- 无缝钢管理论重量表和计算公式
- 云南大学旅游文化学院与法国IPAG商学院0.5+1本硕连读项目
- 2006年普通高等学校招生全国统一考试理科数学
- 教师节感恩老师征文三
- (2019-2020)【重点资料】高中数学 第一章 三角函数 1.1 任意角和弧度制 1.1.2 弧度制学案 新人教A版必修4
- 中级消防员实操考试题目讲解
- 远程医疗项目可行性研究报告